Regd. Office : 11th Floor, Grandeur, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400053, Maharashtra, India
Tel no : +91 22 4001 2000
Fax : +91 22 4001 2011
CIN: L24110MH1992PLC066364
E-mail : info@marksanspharma.com
Website : www.marksanspharma.com
ISIN : INE750C01026
Stock Code : National Stock Exchange of India Limited - MARKSANS
BSE Limited - 524404
Marksans Pharma, headquartered at Mumbai (India) is a global pharmaceutical company. We are actively engaged in R&D and offer CRAMS to global pharmaceutical companies.
Our key focus areas lie in the OTC & prescription drugs that have wide-ranging applications across fields like Oncology, Gastroenterology, Antidiabetic, Antibiotics, Cardiovascular, Pain Management, Gynaecology, among others.
OUR STRENGTH
We have established world-class manufacturing facilities by leveraging state-of-the-art technology, incorporating best practices and adhering to stringent regulatory compliances. Our plants are approved by prestigious US FDA, UK MHRA, Australian TGA and other foreign health authorities.
Our R&D capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development and conducting stability studies. We have a team of over 50 experienced scientists specializing in formulation development and analytical development.
We possess end-to-end capabilities – from Lab scale development to Pilot scale up and from commercializing the product for large scale manufacturing to marketing globally.
The company has achieved global recognition within a very short span of time and has major global expansion plans for the near future.
Marksans Pharma has another manufacturing facility at a multi-purpose UK MHRA licensed factory in Southport, UK. This setup is primarily engaged in manufacturing non-sterile liquids, ointments and powder products.
Comments